Siren LLC’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$48.6M Hold
1,688,611
2.51% 5
2025
Q1
$56.6M Buy
1,688,611
+78,959
+5% +$2.65M 3.19% 5
2024
Q4
$82.3M Buy
1,609,652
+300,000
+23% +$15.3M 3.64% 5
2024
Q3
$66.9M Buy
+1,309,652
New +$66.9M 3.35% 6